Gordian Capital Singapore Pte Ltd Buys Shares of 1,016 Doximity, Inc. (NASDAQ:DOCS)

Gordian Capital Singapore Pte Ltd bought a new stake in shares of Doximity, Inc. (NASDAQ:DOCSGet Rating) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 1,016 shares of the company’s stock, valued at approximately $51,000.

Other institutional investors have also modified their holdings of the company. US Bancorp DE bought a new stake in shares of Doximity during the 3rd quarter valued at $26,000. Rockefeller Capital Management L.P. acquired a new position in shares of Doximity in the 3rd quarter valued at $27,000. Steward Partners Investment Advisory LLC grew its holdings in shares of Doximity by 71.4% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 1,200 shares of the company’s stock valued at $60,000 after buying an additional 500 shares during the period. Huntington National Bank boosted its stake in Doximity by 95.6% in the 4th quarter. Huntington National Bank now owns 1,432 shares of the company’s stock worth $72,000 after purchasing an additional 700 shares during the period. Finally, Royal Bank of Canada acquired a new position in Doximity in the 2nd quarter worth $87,000. Institutional investors own 67.88% of the company’s stock.

Doximity stock traded up $0.66 during trading hours on Friday, hitting $34.58. The company had a trading volume of 5,588 shares, compared to its average volume of 2,403,061. The firm has a market cap of $6.62 billion and a PE ratio of 50.12. Doximity, Inc. has a one year low of $27.06 and a one year high of $107.79. The firm has a 50-day moving average of $43.31 and a 200 day moving average of $50.37.

Doximity (NASDAQ:DOCSGet Rating) last announced its earnings results on Tuesday, May 17th. The company reported $0.21 EPS for the quarter, topping the consensus estimate of $0.15 by $0.06. Doximity had a net margin of 40.52% and a return on equity of 17.73%. The company had revenue of $93.65 million for the quarter, compared to analysts’ expectations of $90.17 million. The firm’s quarterly revenue was up 40.4% compared to the same quarter last year. Equities analysts expect that Doximity, Inc. will post 0.6 earnings per share for the current year.

A number of brokerages recently weighed in on DOCS. Zacks Investment Research lowered shares of Doximity from a “buy” rating to a “hold” rating in a research note on Wednesday. Canaccord Genuity Group reduced their target price on shares of Doximity from $65.00 to $44.00 in a research note on Wednesday, May 18th. Robert W. Baird reduced their price objective on shares of Doximity from $68.00 to $45.00 in a research note on Wednesday, May 18th. Guggenheim reduced their price objective on shares of Doximity from $70.00 to $52.00 and set a “buy” rating for the company in a research note on Wednesday, May 18th. Finally, Raymond James reduced their price objective on shares of Doximity from $60.00 to $40.00 in a research note on Wednesday, May 18th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $49.07.

In related news, Director Kira Scherer Wampler sold 2,200 shares of the stock in a transaction that occurred on Friday, April 1st. The shares were sold at an average price of $53.10, for a total transaction of $116,820.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CRO Paul W. Jorgensen purchased 15,000 shares of Doximity stock in a transaction that occurred on Friday, May 20th. The shares were purchased at an average price of $32.19 per share, for a total transaction of $482,850.00. Following the transaction, the executive now directly owns 197,676 shares in the company, valued at approximately $6,363,190.44. The disclosure for this purchase can be found here.

About Doximity (Get Rating)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's cloud-based platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.

Featured Stories

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCSGet Rating).

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.